
Prevalence of statin intolerance: a meta-analysis
Abstract Aims Statin intolerance (SI) represents a significant public health problem for which precise estimates of prevalence are needed. Statin intolerance remains an important clinical
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Abstract Aims Statin intolerance (SI) represents a significant public health problem for which precise estimates of prevalence are needed. Statin intolerance remains an important clinical
https://ilep.eu/wp-content/movies/20221008082604_live7603_2022-10-08-07.47.08.515-UTC.mp4
The 1st ILEP Symposium has come to an end. Finally, we are ready to share the official statistics of this event. Please see the attached
We are pleased to invite you to participate in a free webinar organized by the European Atherosclerosis Society (EAS) together with The Polish Lipid Association,
Inflammation plays a central role in the pathogenesis and clinical manifestations of atherosclerosis. Randomized controlled trials have investigated the potential benefit of colchicine in reducing
Familial hypercholesterolaemia (FH) is a genetic and complex multifactorial lipid disorder, which increases the risk of premature atherosclerosis and coronary artery disease. FH is still
Fig. 1. Direct potential causes of myocarditis. Myocarditis is an inflammatory disease of the myocardium that mostly affects young adults. The disease is commonly caused
A new paper has been published about the association of statin use in older people primary prevention group with risk of cardiovascular events and mortality.
ILEP strongly believes in international cooperation, which is why the presence of representatives of all nationalities in our ranks is so important. If you are interested in join the ILEP, please click below to see the requirements.
During the last meeting our Experts discussed the efficacy of nutraceuticals in the therapy of lipid disorders.
ILEP Webinars Recommendations 2021
05-10.2021
ILEP Webinars on Nutraceuticals
09-10.2020
In 2020 we have been able to publish 10 papers, in which many of the ILEP members were included:
Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner Ž, Vrablik M, Escobar C.
Banach M, Cannon CP, Paneni F, Penson PE; endorsed by the International Lipid Expert Panel (ILEP).
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP)
ILEP Webinars Recommendations 2021
The 2nd Edition of ILEP Webinars starts.
ILEP hosts the 1st Edition of ILEP Webinars.
Professor Maciej Banach founds the International Lipid Expert Panel.
In case of any questions, please contact the ILEP Secretary – Patrycja Lewandowicz: